Skip to content
Sunday, November 15, 2026
Ultra Club Pro

Patients Stopping Weight-Loss Jabs Gain Back Pounds Four Times Faster Compared to Dieters

Illustration of medical syringe and scale
Weight management often requires long-term strategies.

A recent study reveals that patients who discontinue blockbuster slimming jabs like Mounjaro or Wegovy may regain shed pounds much more quickly than those who stop traditional lifestyle programs.

Research printed in a major medical journal demonstrates that while obese individuals can lose about a fifth of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"Users using these drugs need to be aware of the potential of rapid weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.

This pace of regain implies a reversion to pre-treatment weight within about 18 months.

Comparing Treatments

The research, which examined dozens of studies involving over 9,000 of participants, contrasted the results of GLP-1 agonists with conventional dieting.

Researchers point out that people who lose weight through diet and exercise usually see a less rapid creep back—around 100 grams monthly—once they finish.

Understanding the Fast Regain

Nutrition scientists suggest the mechanism of the jabs explains the accelerated rebound.

These medications mimic a body's own chemical called glucagon-like peptide-1, which moderates hunger.

"Artificially providing the hormone concentrations far above than normal may cause the body to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this hormone supplement results in hunger is no longer kept in check, making overeating far more likely."

An Ongoing Issue?

Health authorities suggest the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals argue that, due to the high risk of relapse, the treatment might need to be ongoing.

This perspective is supported by pharmaceutical companies, who note that the findings "highlight the persistent nature of obesity," akin to managing diseases like diabetes.

Patient Accounts

Individuals who have discontinued the jabs report a intense resurgence of cravings.

"I experienced something flipping and you're instantly extremely hungry," said a patient.

This challenge is exacerbated if individuals have not adopted lasting dietary or behavioural modifications during treatment.

Growing Use

Survey data show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.

  • Use is greater among females compared to males.
  • The middle-aged demographic shows the highest usage rates.
  • A large proportion access the medications through private healthcare rather than the NHS.

In conclusion, experts caution that while these medications are effective agents for shedding pounds, they are not a standalone fix and maintained weight loss hinges on ongoing behavioural changes.

MB
The writer

Maria Brown

A certified personal trainer and fitness writer with over a decade of experience in sports nutrition and strength conditioning.

Ultra Club Pro

Type to search articles.